← Leaderboards
Rajesh A Patel
Titan Pharmaceuticals, Inc.
$3,697,500
Attributed
$3,945,000
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.5M · FY2010–25$5M$3.8M$2.5M$1.3M$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,945,000 · 2
By mechanism
UH3$3,450,000 · 1
R43$495,000 · 1
Top collaborators
- Sunil P Sreedharan2 shared
Most similar at Titan Pharmaceuticals, Inc.
Same institution · by research overlap
- Katherine Beebe Devarney$27,187,371
- Sunil P Sreedharan$247,500
Others in their field
Top investigators on “Vinyl Acetate”
- Katherine Beebe Devarney · Titan Pharmaceuticals, Inc.$16,328,440
- Laura E Niklason · Duke University$2,048,264
- Akira Takashima · University Of Texas Sw Med Ctr/Dallas$1,863,953
- Kim A. Woodrow · University Of Washington$1,851,048
- Jeffrey T. Jensen · Oregon Health And Science University$1,851,048
- Steven D. Burke · University Of Wisconsin Madison$1,846,300
Research focus
Vinyl AcetatePreventPlasmaTitanCanis FamiliarisDrug KineticsOpiate AddictionPharmaceutical PreparationsSafetyTechnologyEthylenesAnimalsImplantSubcutaneousChronicImplantationOral AdministrationClinical ResearchDoseFunctional DisorderApomorphineEmployee StrikesImplantable Infusion PumpsDrug Formulations
Grant awards (3)
Nalmefene Implant for the Long-Term Treatment of Opioid Use Disorder$3,450,000
UH3 · FY2025 · DA · contact PI
Long-term non-fluctuating dopamine agonist delivery for Parkinson's disease$195,000
R43 · FY2011 · NS
Long-term non-fluctuating dopamine agonist delivery for Parkinson's disease$300,000
R43 · FY2010 · NS